Packaging Specifications. PORTIONS OF THIS EXHIBIT WERE OMITTED AND HAVE BEEN FILED SEPARATELY WITH THE SECRETARY OF THE COMMISSION PURSUANT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT UNDER RULE 406 OF THE SECURITIES ACT; [***] DENOTES OMISSIONS. 100 mg testosterone undecanoate Bulk softgels [***] 150 mg testosterone undeanoate Bulk softgels [***] 100 mg testosterone undecanoate Bulk softgels [***] softgels 150 mg testosterone undecanoate Bulk softgels [***] softgels Product Maintenance Fee [***] Annually Commercial Occupancy Fee [***] Annually PORTIONS OF THIS EXHIBIT WERE OMITTED AND HAVE BEEN FILED SEPARATELY WITH THE SECRETARY OF THE COMMISSION PURSUANT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT UNDER RULE 406 OF THE SECURITIES ACT; [***] DENOTES OMISSIONS.
Appears in 2 contracts
Sources: Softgel Commercial Manufacturing Agreement (Clarus Therapeutics Inc), Softgel Commercial Manufacturing Agreement (Clarus Therapeutics Inc)